Alkermes (ALKS) Capital Expenditures (2010 - 2026)

Alkermes (ALKS) has reported Capital Expenditures for 17 consecutive years, with $8.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 37.42% year-over-year to $8.1 million in Q2 2026; TTM through Jun 2026 was $29.5 million, a 28.25% decrease from a year earlier, with the FY2025 full-year figure at $40.4 million, up 20.71% from the prior year.
• Capital Expenditures was $8.1 million for Q2 2026 at Alkermes, up from $4.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $17.3 million in Q3 2025 and troughed at -$20000.0 in Q4 2025.
• A 5-year average of $9.6 million and a median of $9.7 million in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 117.62% in 2022 and plunged 100.2% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $10.0 million in 2022, then soared by 69.82% to $17.0 million in 2023, then tumbled by 42.61% to $9.8 million in 2024, then plunged by 100.2% to -$20000.0 in 2025, then surged by 40830.0% to $8.1 million in 2026.
• The last three Capital Expenditures figures came in at $8.1 million (Q2 2026), $4.1 million (Q1 2026), and -$20000.0 (Q4 2025), per Business Quant data.